Empresa ERYTECH Pharma LIQUIDNET SYSTEMS
Acciones
FR0011471135
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23/06/23 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23/06/23 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23/06/23 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23/06/23 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23/06/23 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23/06/23 |
General Counsel | - | 23/06/23 | |
Human Resources Officer | - | 23/06/23 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23/06/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 63 | 23/06/23 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23/06/23 |
Gil Beyen
BRD | Director/Board Member | 62 | 23/06/23 |
Martine George
BRD | Director/Board Member | 76 | 23/06/23 |
Director/Board Member | 66 | 23/06/23 | |
Didier Hoch
CHM | Chairman | 68 | 23/06/23 |
Leila Nicolas
BRD | Director/Board Member | - | 23/06/23 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 11 137 712 | 10 660 161 ( 95,71 %) | 270 ( 0,002429 %) | 95,71 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
250 | 0.00% | 813 $ |
Información de la empresa
![Dirección ERYTECH Pharma](https://cdn.zonebourse.com/static/address/35055710.png)
Sector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,58 % | 122 mil M | |
+16,60 % | 113 mil M | |
+17,55 % | 26,22 mil M | |
-24,33 % | 19,01 mil M | |
-19,14 % | 15,71 mil M | |
-17,95 % | 15,22 mil M | |
-46,81 % | 14,72 mil M | |
+58,78 % | 14,58 mil M | |
+4,91 % | 13,84 mil M |